feedback

Course Director

Diane McIntosh, BSc Pharmacy, MD, FRCPC
Diane McIntosh, BSc Pharmacy, MD, FRCPC

University of British Columbia
Vancouver, British Columbia

Accredited by

Queen's University Office of CPD

View Activity Materials

Activity Details

Credit Types:CME
Credit Amount:0.75 Credits
Release Date:2019-Feb-21
Expiration Date:2020-Feb-20
Estimated Time for Completion:45 minutes
Registration Required:No
Cost:Free of Charge

Funding Disclosure

This activity is supported by an educational grant from Sunovion Pharmaceuticals Canada Inc.

Activity Description and Educational Objectives

In this activity, an expert explores management strategies for bipolar disorder, using compelling patient stories to highlight how clinicians can recognize bipolar depression and develop long-term treatment plans for patients that account for the chronicity of this condition.

Upon completion of this activity, participants should be better able to:
  • Distinguish bipolar from unipolar depression
  • Apply bipolar depression treatment recommendations outlined in the CANMAT/ISBD 2018 guidelines
  • Formulate management strategies that take into consideration the chronicity of bipolar disorder and the need for long-term treatment

Target Audience

This activity has been designed to meet the educational needs of Canadian psychiatrists and other clinicians involved in the management of patients with bipolar depression.

Faculty Disclosure Statement / Conflict of Interest Policy

Queen's University Office of CPD has assessed conflict of interest with its faculty, authors, editors, and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Queen’s planners, medical reviewers, and editorial staff disclose no relevant financial relationships with commercial interests.

Activity Chair

Diane McIntosh, BSc Pharmacy, MD, FRCPC
Clinical Assistant Professor
University of British Columbia
Vancouver, British Columbia

Diane McIntosh, BSc Pharmacy, MD, FRCPC, has a financial interest/relationship or affiliation in the form of:
Consultant for AbbVie Corporation; Allergan Inc.; Bristol-Myers Squibb Canada Co; Eli Lilly and Company; Janssen Inc.; Lundbeck Canada Inc.; Otsuka Canada Pharmaceutical Inc.; Pfizer Inc; Purdue Pharma Canada; Shire Plc; Sunovion Pharmaceuticals Canada Inc.; and Valeant Pharmaceuticals International, Inc.
Speakers Bureau participant with AbbVie Corporation; Allergan Inc.; Bristol-Myers Squibb Canada Co; Eli Lilly and Company; Janssen Inc.; Lundbeck Canada Inc.; Otsuka Canada Pharmaceutical Inc.; Pfizer Inc; Purdue Pharma Canada; Shire Plc; Sunovion Pharmaceuticals Canada Inc.; and Valeant Pharmaceuticals International, Inc.
Honoraria from AbbVie Corporation; Allergan Inc.; Bristol-Myers Squibb Canada Co; Eli Lilly and Company; Janssen Inc.; Lundbeck Canada Inc.; Otsuka Canada Pharmaceutical Inc.; Pfizer Inc; Purdue Pharma Canada; Shire Plc; Sunovion Pharmaceuticals Canada Inc.; and Valeant Pharmaceuticals International, Inc.
Advisory Board for AbbVie Corporation; Allergan Inc.; Bristol-Myers Squibb Canada Co; Eli Lilly and Company; Janssen Inc.; Lundbeck Canada Inc.; Otsuka Canada Pharmaceutical Inc.; Pfizer Inc; Purdue Pharma Canada; Shire Plc; Sunovion Pharmaceuticals Canada Inc.; and Valeant Pharmaceuticals International, Inc.

Planning Committee Chair

Roumen Milev, MD, PhD, FRCPsych, FRCPC
Providence Care Hospital
Kingston, Ontario

Roumen Milev, MD, PhD, FRCPsych, FRCPC, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from Boehringer Ingelheim (Canada) Ltd.; Janssen Inc.; Lundbeck Canada Inc.; Merck Canada Inc.; OBI Pharma, Inc.; Ontario Mental Health Foundation; Pfizer Canada Inc.; The Canadian Biomarker Integration Network in Depression; and The Canadian Institutes of Health Research.
Honoraria from Allergan Inc.; Bristol-Myers Squibb Canada Co; Janssen Inc.; Lundbeck Canada Inc.; Otsuka Pharmaceutical Co., Ltd.; Pfizer Canada Inc.; Shire Plc; and Sunovion Pharmaceuticals Canada Inc.
Advisory Board for Allergan Inc.; Bristol-Myers Squibb Canada Co; Lundbeck Canada Inc.; Otsuka Pharmaceutical Co., Ltd.; Pfizer Canada Inc.; Shire Plc; and Sunovion Pharmaceuticals Canada Inc.

Planning Committee Member

Dianne Groll, PhD
Queen's University
Kingston, Ontario

Dianne Groll, PhD, has no financial interests/relationships or affiliations in relation to this activity.

PeerVoice Medical Director

Judah Issa has no financial interests/relationships or affiliations in relation to this activity.

Disclosure of Unlabelled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labelled for use in certain jurisdictions. Faculty members have been advised to disclose to the audience any reference to an unlabelled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our materials. No responsibility is taken for errors or omissions in our materials.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

This activity contains discussions of product(s) and/or uses, which, as of publication, are not yet licensed in Canada. Please check Health Canada at www.hc-sc.gc.ca for up-to-date information.

Accreditation

Maintenance of Certification Section 1 Credit

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and approved by Queen's University Office of CPD. You may claim a maximum of 0.75 hours (credits are automatically calculated).

This CME activity is jointly provided by Queen's University Office of CPD and PeerVoice.

Requirements for Successful Completion

To receive credit, participants must complete the activity, the post-test, and the evaluation form prior to the expiration date noted below. There are no pre-requisites and there is no fee to participate in this activity or to receive credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form. Consult your professional licensing board for information about your eligibility to claim credit for participation in this educational activity. A minimum performance level of 80% is needed.

Media: Enduring Material
Release and Expiration Dates: 21 February 2019 - 20 February 2020
Estimated Time to Complete: 45 minutes

Disclaimer

The participants of this educational activity have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerVoice or any of its supporters.

The development of PeerVoice activities follows the requirements of Health Canada, the Canadian Medical Association, and the Innovative Medicines Canada Code of Ethical Practices.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.